Gammagard Liquid 10%: Completed Phase III enrollment

Baxter completed enrollment of 390 AD patients ages 50-89 in a double-blind, placebo-controlled, U.S. and Canadian Phase III trial evaluating 200 and 400 mg/kg IV Gammagard Liquid 10% every 2 weeks fo...